Placental Maternal Health Conditions

Last uploaded: January 13, 2020
Preferred Name

Hyperparathyroidism

Synonyms

Hyperparathyroidism (disorder)

PARATHYROID, HYPERFUNCTION

HPTH - Hyperparathyroidism

Hyperparathyroidism NOS

hyperparathyroidism

Hyperparathyroidism [Disease/Finding]

Hyperparathyroidism, unspecified

Elevated blood parathyroid hormone level

Definitions

[NCIt Definition]: Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It may be primary or secondary; primary hyperparathyroidism is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones. Secondary hyperparathyroidism is caused by the chronic stimulation of the parathyroid glands in patients with chronic renal failure, rickets, and malabsorption syndromes. [MSH Definition]: A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES. [CTCAE Definition]: A disorder characterized by an increase in production of parathyroid hormone by the parathyroid glands. This results in hypercalcemia (abnormally high levels of calcium in the blood). [HPO Definition]: Excessive production of parathyroid hormone (PTH) by the parathyroid glands. [HPO:probinson] [NICHD Definition]: Elevated concentration of parathyroid hormone. Causes include conditions originating within the parathyroid glands (primary), in response to hypocalcemia and hyperphosphatemia (secondary), and renal disease (tertiary). Characteristics may include polyuria, polydipsia, constipation, lethargy, cognitive dysfunction, hypercalciuria, nephrolithiasis, and bone demineralization or reduced bone mineral density. [NCI-GLOSS Definition]: A condition in which the parathyroid gland (one of four pea-sized organs found on the thyroid) makes too much parathyroid hormone. This causes a loss of calcium from the bones and an increased level of calcium in the blood. Symptoms include bone pain and kidney problems. [CSP Definition]: abnormally increased activity of the parathyroid glands, which may be primary or secondary; primary hyperparathyroidism is associated with neoplasia or hyperplasia; excess of parathyroid hormone leads to alteration in function of bone, renal tubules, and gastrointestinal mucosa. [PDQ Definition]: Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It may be primary or secondary; primary hyperparathyroidism is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones. Secondary hyperparathyroidism is caused by the chronic stimulation of the parathyroid glands in patients with chronic renal failure, rickets, and malabsorption syndromes. Check for active clinical trials using this agent. (NCI Thesaurus)

ID

http://pat.nichd.nih.gov/maternalconditions/C0020502

Definition

[NCIt Definition]: Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It may be primary or secondary; primary hyperparathyroidism is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones. Secondary hyperparathyroidism is caused by the chronic stimulation of the parathyroid glands in patients with chronic renal failure, rickets, and malabsorption syndromes.

[MSH Definition]: A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.

[CTCAE Definition]: A disorder characterized by an increase in production of parathyroid hormone by the parathyroid glands. This results in hypercalcemia (abnormally high levels of calcium in the blood).

[HPO Definition]: Excessive production of parathyroid hormone (PTH) by the parathyroid glands. [HPO:probinson]

[NICHD Definition]: Elevated concentration of parathyroid hormone. Causes include conditions originating within the parathyroid glands (primary), in response to hypocalcemia and hyperphosphatemia (secondary), and renal disease (tertiary). Characteristics may include polyuria, polydipsia, constipation, lethargy, cognitive dysfunction, hypercalciuria, nephrolithiasis, and bone demineralization or reduced bone mineral density.

[NCI-GLOSS Definition]: A condition in which the parathyroid gland (one of four pea-sized organs found on the thyroid) makes too much parathyroid hormone. This causes a loss of calcium from the bones and an increased level of calcium in the blood. Symptoms include bone pain and kidney problems.

[CSP Definition]: abnormally increased activity of the parathyroid glands, which may be primary or secondary; primary hyperparathyroidism is associated with neoplasia or hyperplasia; excess of parathyroid hormone leads to alteration in function of bone, renal tubules, and gastrointestinal mucosa.

[PDQ Definition]: Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It may be primary or secondary; primary hyperparathyroidism is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones. Secondary hyperparathyroidism is caused by the chronic stimulation of the parathyroid glands in patients with chronic renal failure, rickets, and malabsorption syndromes. Check for active clinical trials using this agent. (NCI Thesaurus)

External Source

https://ncim.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI%20Metathesaurus&code=C0020502

Label

Hyperparathyroidism

notation

C0020502

PAT ID

C0020502

prefLabel

Hyperparathyroidism

Sub Class Of

http://pat.nichd.nih.gov/maternalconditions/C0030517

Synonyms

Hyperparathyroidism (disorder)

PARATHYROID, HYPERFUNCTION

HPTH - Hyperparathyroidism

Hyperparathyroidism NOS

hyperparathyroidism

Hyperparathyroidism [Disease/Finding]

Hyperparathyroidism, unspecified

Elevated blood parathyroid hormone level

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/DOID_13543 DOID LOOM
http://nanbyodata.jp/ontology/NANDO_2100123 NANDO LOOM
http://nanbyodata.jp/ontology/NANDO_2200343 NANDO LOOM
http://purl.obolibrary.org/obo/DOID_13543 DOID LOOM
rgo:22568 GAMUTS LOOM
rgo:22568 GAMUTS LOOM
http://www.ebi.ac.uk/efo/EFO_0008506 EFO LOOM
http://purl.obolibrary.org/obo/HP_0000843 EFO LOOM
http://purl.obolibrary.org/obo/HP_0000843 HP LOOM
http://purl.obolibrary.org/obo/HP_0000843 OBA LOOM
http://purl.obolibrary.org/obo/HP_0000843 MAXO LOOM
http://purl.obolibrary.org/obo/MONDO_0001741 MONDO LOOM
http://purl.obolibrary.org/obo/HP_0000843 OBA LOOM
http://purl.obolibrary.org/obo/DOID_13543 DTO LOOM
http://purl.obolibrary.org/obo/DOID_13543 BAO LOOM
http://purl.obolibrary.org/obo/DOID_13543 HHEAR LOOM
http://purl.obolibrary.org/obo/DOID_13543 NIFSTD LOOM
http://purl.obolibrary.org/obo/DOID_13543 MIDO LOOM
http://purl.obolibrary.org/obo/DOID_13543 FNS-H LOOM
http://purl.bioontology.org/ontology/RCTV2/C120.00 RCTV2 LOOM
http://purl.bioontology.org/ontology/WHO/0921 WHO-ART LOOM
http://purl.bioontology.org/ontology/ICD9CM/252.0 ICD9CM LOOM
http://www.phoc.org.cn/pmo/class/PMO_00085354 PMAPP-PMO LOOM
http://www.gamuts.net/entity#hyperparathyroidism GAMUTS LOOM
http://www.owl-ontologies.com/NPOntology.owl#DOID_13543 NATPRO LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C19.642.355 RH-MESH LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/66999008 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/MESH/D006961 MESH LOOM
http://www.co-ode.org/ontologies/galen#Hyperparathyroidism GALEN LOOM
http://purl.bioontology.org/ontology/ICPC2P/T99037 ICPC2P LOOM
http://radlex.org/RID/RID34610 RADLEX LOOM
http://purl.bioontology.org/ontology/MEDDRA/10020705 MEDDRA LOOM
http://purl.bioontology.org/ontology/OMIM/MTHU036868 OMIM LOOM
http://purl.jp/bio/4/id/200906033613967569 IOBC LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0020502 OCHV LOOM
http://id.nlm.nih.gov/mesh/D006961 MDM LOOM
http://www.semanticweb.org/ontologies/2012/11/abnormalities.owl#phenodb:2293 IFAR LOOM
http://purl.obolibrary.org/obo/CCTO_000410 CCTOO LOOM
http://purl.bioontology.org/ontology/RCD/XE10M RCD LOOM
http://purl.bioontology.org/ontology/MEDLINEPLUS/C0020502 MEDLINEPLUS LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#6432 OCHV LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/ctcae5.owl#C143557 CTCAE LOOM
urn:agi-folder:hyperparathyroidism BPT LOOM
http://purl.obolibrary.org/obo/MONDO_0001741 DOVES LOOM
http://purl.obolibrary.org/obo/MONDO_0001741 KTAO LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000671547 PDQ LOOM
http://purl.obolibrary.org/obo/NCIT_C48259 BERO LOOM
http://www.owl-ontologies.com/Ontology1358660052.owl#Hyperparathyroidism PEDTERM LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D006961 RH-MESH LOOM
http://purl.obolibrary.org/obo/OMIT_0008095 OMIT LOOM
http://purl.bioontology.org/ontology/CSP/2216-0087 CRISP LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#Hyperparathyroidism CSEO LOOM
http://purl.obolibrary.org/obo/HP_0000843 SCDO LOOM
http://purl.obolibrary.org/obo/HP_0000843 HP LOOM
http://purl.obolibrary.org/obo/HP_0000843 UPHENO LOOM
http://purl.obolibrary.org/obo/HP_0000843 KTAO LOOM
http://purl.org/obo/owl/HP#HP_0000843 BDO LOOM
http://www.semanticweb.org/ontologies/2018/1/ProstateCancer.owl#Hyperparathyroidism PCAO LOOM
http://purl.bioontology.org/ontology/AIR/HYPTH AI-RHEUM LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48259 NCIT LOOM